lar offenses. Animal-control agencies frequently deal with chronic offenders of
leash laws and other ordinances, so recidivism is a good measure of the impact of such laws. Prior to Multnomah 's
revised dangerous-dog law, 25 percent of
all biting dogs had bitten someone else
within one year. Under the new regulations, that rate fell to 7 percent. The number of bites in the community has dropped
by about 8 percent since 1987 and the
number of dangerous-dog cases presented
to animal-control officers has dropped by
18 percent. Mr. Oswald notes that the program has also been an outstanding vehicle
for educating the public and community
leaders to the need for responsible pet
ownership and responsive animal control.
He observed, "We were facing a 75 percent cut in funding, but being able to document the effectiveness of our program
helped lead to full reinstatement of our
budget in a very competitive fiscal arena."
Despite the dramatic rise in awareness
of the problems caused by dangerous dogs,
the widespread adoption of dangerous-dog
laws, and continued successes against dogfighting, there seems to be little evidence
in most areas that the dangerous-dog situation is improving. What is preventing effective solutions?
We know from the experience of Multnomah County and others that strong dangerous-dog laws with good enforcement
can work. However as cities are inct·easingly facing fiscal crises, animal-control
budgets are usually among the first to be
cut. John Snyder, past president of the National Animal Control Association, said,
"In the last year, I have heard many horror
tales about governments taking away what
little resources these agencies have. The
public demands and expects animal-control services, but they have no idea of what
is needed to do it right."
Perhaps the main reason why progress
has been limited is that animal-control
agencies and local humane societies, with
sparse and often diminishing resources,
are attempting to deal with dangerous-dog
problems that have very deep human roots.
The underlying causes are the ways people
breed, raise, train, socialize, and supervise
their animals. It is time to look at what individuals, rather than governments, can do
to end the dog-bite epidemic.
Puppy mills and many other breeders
continue to engage in widespread breeding
of dogs without concern for their inborn
temperament. As more people have ac22

quired dogs primarily for protection, there
has been a rapid rise in the number of
questionable animals from guarding and
fighting breeds finding their way into
nai·ve or irresponsible hands. The result
has been an increase in problems associated with protective breeds such as chows
and rottweilers that have traditionally
shown few problems in the past.
Not all bite problems can be blamed on
those people seeking or breeding animals
for protection. For example the traditional
"family" dog breeds-Labrador and golden
retrievers and cocker spaniels-were involved in more than 12 percent of the severe attacks in Palm Beach County, Florida, in 1991. This may be in part due to
breeding that ignores temperament, but
aggression problems can also result from
improper socialization, training, and care.
How can individual dog owners, as well
as shelters and humane societies, prevent
the dogs they love from becoming part of
the dog-bite problem?
If you arc among the growing number
of people seeking a dog for protection, you
should seriously assess your needs and
motives. Few people really need a guard
dog. For most families an "alert" or "image" dog who will sound the alarm or look
intimidating without actually showing aggression can provide protection without
the risk. Nearly any dog provided with
love, care, and proper training can develop
the kinds of bonds to people that allow
him/her to fill this need while remaining a
safe family companion, so follow the
L-ISUS suggestion to "adopt one" from
your local shelter.
Be sure your pet is spayed or neutered.
Statistics show that unsterilized animals
make up a majority of the biting population.
Urge those who continue to breed dogs
to exercise care and restraint to preserve
the breeds they love. A high rate of breeding of any breed, particularly one with a
guarding or fighting history, not only contributes to pet overpopulation but can also
quickly lead to declines in health and temperament standards. The damage that has
been done to the reputation and quality of
today's "problem" breeds such as rottweilers, Doberman pinschers, and chows may
take years to undo.
All dog owners should socialize and
train their dogs early and well. Training
need not be aimed at meeting some competitive standard. For most pet owners, the
primary goal of training should be to build

a bond of trust and understanding, to set
appropriate limits, and to help the animal
become a trustworthy member of the family. If one establishes a firm foundation of
basic obedience, correcting most dog-behavior problems at an early stage becomes
much easier.
We need to teach children and others
how to behave around strange as well as
familiar dogs to reduce the likelihood of a
bite. Educational materials dealing with
bite prevention are available from The
HSUS and many local organizations.
Animal-control agencies and humane
societies can also focus more on preventing dog-aggression problems rather than
dealing only with their aftermath.
Counseling during the adoption process
should educate new and prospective pet
owners about animal behavior so that they
can have realistic expectations and learn
how to avoid problems. Shelters must try
to provide resources to deal with minor
problems that can escalate to serious aggression. While only a handful of shelters
currently employ full-time trainers or animal behaviorists, such services can pay for
themselves in the form of better adoption
counseling and prevention or correction of
common behavior problems that could
otherwise lead to the return, abandonment,
or impoundment of the dog as a result of a
bite incident. If shelters cannot directly
provide these resources, they can assist in
contacting people in the community who
can provide puppy kindergartens and play
groups, basic obedience training, and animal-behavior counseling.
Animal-protection and animal-control
groups can work together for fair dangerous-dog legislation with strong enforcement that is designed not simply to respond to dangerous-dog problems, but also
to educate the public about responsible pet
ownership.
At a time when stories of dog attacks
continue to fill the media, it is often easy to
forget that most of our more than 50 million dogs never bite anyone. However, the
problems caused by the highly visible minmity of animals and their owners have
far-reaching consequences for all of us
who care about the special relationship between people and dogs. Each of us must renew his/her commitment to seeing that safe
and healthy animals share their lives with
understanding and responsible owners. •

everal recent developments in genetic engineering show how the new industry applies
biotechnology to agriculture and medicine. The value of these new developments in
terms of real progress in improving agricultural practices and human health remains to
be seen. The following examples clearly reveal that a "New Creation," a new world order of the biotechnology industry, is far from any utopian dream of a world made perfect
for humankind.
One can read between the lines of new patent applications, news releases, and scientific reports concerning the latest feats of genetic engineering and glimpse the near future. The
wonder-world of New Creation is not quite here today, but it may be upon us sooner than we
expect. A whole new generation of genetically engineered, or transgenic, animals is on the
way, animals carrying genes transplanted from humans and other species. In the world of commerce, transgenic animals will be regarded as "new" species, the patentable commodities of a
new world order.
Transgenic Animals
cientists in the United States, Canada, Japan, Europe, and Australia have created anumber of transgenic animals: pigs, lambs, calves, and fish who contain the growth-hormone genes of other species, including those of humans. To date, an estimated ten thousand varieties of transgenic mice have been created. However, gene-splicing success
rates are extremely low, and the entire process is time-consuming and costly. Much of
the funding for this research comes from the public via tax revenues.

Randall Lockwood, Ph.D, is HSUS vice
president, Field Serl'ices.

Michael W Fox, D.Sc., Ph.D., B. Vel. Med., MRCVS, is HSUS vice president. Farm Animals and Bioetlzics. His new book
dealing with genetic engineering, Superpigs and Wondercom, will be published thisfall by Ll'ons and Burford.

By Michael W. Fox, D.Sc., Ph.D., B. Vet. Med., MRCVS
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Researchers at the University of California at Davis
opted to splice extra growth-regulating genes from
sheep into lambs to avoid the use of human gene tissue because, according to scientist James Murray,
" ... transgenes composed entirely of sheep-gene sequences would be more acceptable to laypersons, in
particular, to consumers." Dr. Murray hoped to develop
a strain of sheep whose lambs would efficiently convert their feed and rapidly grow to marketable size. But
the transgenic lambs developed diabetes and other severe health problems that killed them before they ever
reached puberty. Dr. Murray concluded, "The cause of
death varied, but there is clear data that the overexpression of GH [growth hormone] adversely affects liver,
kidney, and cardiac function."'
Merck and Company, an international pharmaceutical firm, applied for a patent in Europe on a "superchicken" it called Macro-Chicken. In the hopes of cornering the worldwide poultry market with highly feedefficient, fast-growing birds, Merck developed the
Macro-Chickens, a line of broiler chickens that carry
the growth gene from cattle.' Merck's Macro-Chickens
may well have a variety of health problems, but if the
birds eat well and grow quickly, they may be ready for
slaughter before severe health problems ever develop.
What will happen to the reserve stock of transgenic
chickens, the ones not raised for slaughter? Will they
suffer?
Because such information is proprietary, corporations are not likely to reveal the problems and risks of
their new patentable creations. Trade secrets notwithstanding, creating transgenic farm animals has social
and economic consequences for farmers, agribusiness
distributors, and consumers-consequences that have
been given scant attention.
Critics of the genetic engineering of farm animals
have questioned the use of public funds to make these
animals produce more meat (even if it is leaner) when
the short- and long-term costs of such research are not
considered (see the Spring 1990 HSUS Nevvs). A major
problem of modern intensive animal agriculture is
overproduction. In many nations, meat and milk overproduction is a chronic problem. It is unlikely that the
creation of transgenic farm animals will help feed the
hungry of the world, since meat-production efficiency
has built-in limitations and inevitable environmental
costs.'
Genetic engineers are now attempting to alter milk
from sheep and cows to be suitable for people who are
lactose intolerant." Researchers are inserting into calf
embryos the human genes responsible for the production of proteins in mother's milk. They hope to create a
new generation of cows able to produce "humanized,"
or more digestible, mille' Such research may be more
helpful in feeding the hungry since milk production is
far more efficient, ecologically sound, and cost-effective than meat production.
Australian government scientists have used genetic
engineering to make sheep produce more wool. The
body chemistry of the sheep is altered so the animal
can convert sulfur-bearing compounds into methionine,
24

an amino acid that increases wool growth." The Australians have also genetically engineered a hormone
that can be injected into sheep to make them shed their
fleece; it eliminates shearing costs. However, the hormone has caused pregnant sheep to abort. These scientists plan to genetically engineer sheep who secrete insect repellent from their hair follicles to ward off blowflies, which cost the sheep industry $85 million a year
in losses. As a spinoff they hope that the sheep will also produce the world's first moth-proof wooLMost genetic-engineering research on farm animals
has focused on increasing productivity; genetic engineering to increase resistance to disease is still very
much in its infancy.' This disease-resistance research is
questionable since improvements in farm-animal husbandry are surely more cost-effective ways of improving animal health and well-being.

Transgenic "Molecular Pharming"
enetic engineers have inserted human genes
into farm animals to produce salable pharmaceutical products such as blood with
blood-clotting factors and other substances.
Harvey Bialy, editor of Bio/Technologv
magazine, has praised what he terms "molecular pharming technologies," as exemplified by research teams from the United Kingdom, the United
States, and the Netherlands that have produced transgenic sheep whose milk contains human alpha-1-antitrypsin; transgenic goats who secrete a human tissuetype plasminogen activator, called t-PA, into their milk;
and the first transgenic dairy cattle. "Taken together,"
he writes, "their results provide a convincing demonstration of the feasibility of using animals as commercial bioreactors.'"'
Recently DNX, a biotechnology company in
Princeton, New Jersey, reported that it has developed a
line of transgenic pigs able to produce human hemoglobin.'" Companies in the United States and the United Kingdom are developing transgenic pigs with human immune systems to serve as organ donors for people needing new hearts and other organ parts. It may
be many years before these new animals provide any
medical products for humans, but venture capitalists
are investing now in this speculative line of research
and development.

Other Innovations
ther developments in farm technology that
do not entail gene transfer but which can
have profound social and economic ramifications include the development of cow
clones" and a technique to preselect the sex
of offspring." Scientists are baffled by the
fact that some 25 percent of calves produced by
cloning are almost twice normal size at the time of
birth and must therefore be delivered by cesarean section.
To date no plant genes have been inserted into animals, but animal genes have been successfully incorporated into the genetic struch1re of various plants. ReHSUS NEWS • Fall 1992
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searchers have successfully implanted human genes into tobacco plants to produce functioning human antibodies that may be used to diagnose and treat human
diseases. The "antifreeze" gene of the flounder, which
produces a protein to stop the fish from freezing, has
been cloned and inserted into tomatoes and tobacco. In
the fuh1re, fish genes may protect such crops from
frost.''
Fish farming is growing, so biotechnologists have
been busy developing "superfish" by inserting growthhormone genes from humans, cattle, chickens, mice, or
other species of fish into a variety of commercially
raised fish, such as carp, rainbow trout, catfish, Atlantic salmon, walleye, and northern pike. The antifreeze gene of the f1ounder is also being inserted into
other fish species to expand commercial fish production in cold regions.'·'
At the Army Research Laboratory in Natick, Massaclmsetts, biotechnologists cloned the silk-producing
gene of the Golden Orb weaver spider and spliced it into bacteria that in turn produce large quantities of spider-silk protein. Stronger than silkworm silk and perhaps even stronger than steel, this product may have
wide commercial applications, including new fabrics
for bullet-proof vests, helmets, parachute cords, and
other types of strong, light equipment.''
Working on the frontier of medicine, scientists have
created a variety of transgenic mice and rats. One family of transgenic mice carries human genes that result
in deformed red blood cells. Research using the mice
has provided a new model for sickle-cell anemia.'" Researchers also developed a line of rats that carries the
human gene HLA-827, which causes a painfully crippling form of arthritis." Not only has the clinical effectiveness of many of these new research efforts not yet
been demonstrated, but there is also no foreseeable
benefit to the animals made transgenic.
Researchers continue trying to identify the genes
responsible for various inherited diseases (especially
those found in purebred dogs and livestock) and the
genes that play a role in development, growth, milk or
egg production, disease resistance, and other physiological processes in animals. U.S. Department of Agriculture (USDA) scientists have recently been given $2
million to start mapping the genes of cattle and pigs.
The result of such costly research may eventually benefit animals in terms of their health and overall wellbeing, but the benefits will be limited if the focus of
the research is too narrow. Unless the DNA-mapping
research is integrated with a more holistic approach to
improving animal health and well-being, it may only
exploit animals.
Most research on DNA structures has focused on
identifYing genetic defects and strengths in humans. All
to what end? The discoveries will certainly lead to new
medical and veterinary products and services, but genetic deten11inism may ultimately lead to eugenics, the
science of improving the hereditary qualities of a race
or breed. In my view eugenics means genetic imperialism. Do we really want or need such a thing-Creation
made over into the human image of perfect utility?
HSUS NEWS • Fall 1992

New Animal Drugs
- - - he development of genetically engineered vaccines, hormones, immune-system enhancers,
birth-control regulators, and diagnostic tests
may benefit animals. However, this new generation of veterinary products and services
may also be a mixed blessing. It is not without
potentially adverse animal-health, socioeconomic, and
ecological consequences. Such products are no substitute for sound breeding, good nutrition, and humane
animal husbandry.

Public Attitudes

This transgenic

private-industry and governmentfunded research centers strive to create
genetically engineered animals who may
prove profitable to agribusiness and to
the medical-industrial complex, the public views such research with some apprehension. In a recent poll of Europeans:
fewer than hall thought biotechnological research on
farm animals "to make them resistant to disease, or
grow faster" should be encoumged. A third thought
applying biotechnology to animals "to develop lifesaving drugs or study human diseases" was mora/lv
acceptable, "provided the animals' >ve/fctre is safeguarded," but 20 percent said it was morally wrong,
and 2 7 percent said government should decide each
case. Onlv 13 percent thought such work justified
"some animal suffering.""
A national survey in Japan revealed that 67 percent
of respondents were opposed to research that could
lead to new forms of plant or animal life.'''
In 1985 opinion polls in the United States showed
that 34 percent of the attentive (informed) public
wished to prohibit the creation of new forms of animal
and plant life.cr'
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"geep," the result of
mixing goat and
sheep genes, was
born in Cambridge,
England, in 1982.
Most genetic-engineel'ing research on
farm animals has focused on inCI'easing
animal productivity.

Animal Patenting

mal patents is that, to date, there is no clear regulatory
structure for the commercial marketing of transgenic
animals."
The Senate is currently considering a bill (S. 1291)
sponsored by Senator Hatfield to impose a five-year
moratorium on the granting of patents on invertebrate
and vertebrate animals, including those having been
genetically engineered. A similar bill (H.R. 4989) was
introduced in the House by Rep. Benjamin Cardin in
April 1992. The HSUS supports both bills.
On the day Senator Hatfield's bill was introduced,
this statement from The HSUS appeared in the Congressional Record:
In order for society to reap the .fit!! benefits of advances in genetic engineering biotechnology, the social, economic, environmental, and ethical ramifications and consequences of such advances need to be
.fitlly assessed. Considering the rapid pace of developments in this .field, vvhich will be spurred on by the
granting of patents on genetically altered animals, a
five-year moratorium on the granting ofsuch patents is
a wise and necessmy decision. A moratorium will enable Congress to .fitlly assess, considm~ and respond to
the economic, environmental. and ethical issues raised
by the patenting of such animals and in the process, establish the United States as the world leader in the
safe, appropriate, and ethical applications of genetic
engineering biotechnology for the benefit of society
andfor generations to come. 21
It is very likely that the White House Council on
Competitiveness, chaired by Vice President Dan
Quayle, will try to block this bill. The council is actively working to deregulate the entire biotechnology industry and has proposed administrative and regulatory
guidelines for the Environmental Protection Agency
and the USDA.'" If these guidelines are adopted, animal welfare, environmental needs, and all of the possible adverse consequences of such new developments in
biotechnology will be virtually ignored.
Although the genetic engineering of animals is not
likely to end, greater public awareness of and debate
over the critical issues of biotechnology are clearly essential. A five-year moratorium on the patenting of
"new" animal creations would be prudent and timely,
notified GenPharm International of Mountain View, especially since the United States is moving toward a
California, that patents will soon be issued on two of new world order of free trade. Free-trade agreements
the company's mice, the TIM (transgenic immunodefi- should require all nations to adopt regulations and
stringent controls over biotechnology. Otherwise the
cient) and cancer-prone PIM lines.
Officials of the U.S. government and multinational privatization of the world's resources and of the genetic
corporations have been pushing for changes in Euro- material of life itself, coupled with the misapplication
pean patent laws that currently prohibit the patenting of genetic engineering in agriculture and medicine,
of animals. 21 The U.S. State Department effectively will oppose the public interest and the public good of
squashed the Rose and Hatfield bills on the grounds generations to come.
that they would weaken U.S. economic competitiveConclusion
ness in the world marketplace.
,._..,.. o understand and evaluate the costs and conSome 145 patent applications for genetically engisequences and the risks and benefits of all
neered animals are now awaiting approval at the U.S.
new developments in science, technology, and
Patent and Trademark Office. Approximately 80 perindustry, one must consider several interrelatcent of such patent applications have medical utility,
ed dimensions. Genetic-engineering biotechwhile the remainder involve agriculhtral animals. One
nology and the patenting of its processes and
possible explanation for the delay in awarding new ani-

products must be viewed from these perspectives: ethical and spirihml, moral and religious, legal and political, social and economic, environmental and culrural.
Because these areas of concern, constraint, and direction have been virhmlly ignored by policymakers or
seen as obstacles to economic growth and industrial
expansion, the gap between private (corporate) and
public interest has widened.
Today we witness the rise of a global industrial
bioteclmocracy, which needs to be rigorously evaluated. To question this development should not be misjudged as antiscience or antiprogress. With greater involvement, an informed public can direct the policymaking process. Advances in science and technology,
in biotechnology in particular, may then serve the public good and help enhance the quality of life and the
environment alike.
Today the U.S. government is attempting to deregulate the biotechnology industry, and the European
Community's Commission on Biotechnology is trying

to eliminate socioeconomic considerations in the licensing of new animal drugs. Clearly the biotechnocracy of the industrialized world is proceeding neither
prudently nor appropriately."
Despite the many documented health problems of
transgenic mice carrying human, bovine, rat, and sheep
growth genes,"' research continues along the same
lines with farm animals. One must wonder how such
suffering can ever be justified, when transgenic pigs,
designed to be lean and to grow quickly, develop pericarditis; enlarged hearts, livers, and other internal organs; enlarged and heavier bones; arthritis; diabetes;
loss of appetite; sterility; respiratory distress; and increased stress and disease susceptibility. 27 '" Even if fuhJre improvements in gene-insertion techniques reduce
health problems suffered by farm animals genetically
engineered for human consumption, the legacy of the
suffering that animals endured in the early stages of the
technology's development should keep anyone from
consuming such animals in good conscience.
•
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he controversy over patenting genetically engineered animals began on April 7, 1987,
when the U.S. Patent and Trademark Office
ruled that such animals, provided that they
were nom1aturally occurring "manufachJres"
and "compositions of matter," could be included under Section 10 I of the Patent Act as
patentable subject matter. The patenting of animals
was vigorously opposed by The HSUS and a coalition
of other organizations.
In 1987 Rep. Charlie Rose introduced legislation to
impose a moratorium on the patenting of animals so
that the potential adverse implications of such patenting could be carefully studied. In 1988 Sen. Mark Hatfield introduced a similar moratorium bill in the Senate. (Neither bill became law.) On April 13, 1988, the
U.S. Patent and Trademark Office issued patent number 4,736,866 to Harvard University and Du Pont
Chemical Company for the "Onco Mouse," a genetically engineered, cancer-prone mouse. Since then no
other animal patents have been awarded in the United
States. But the U.S. Patent and Trademark Office has

Five sheep cloned
from a single embryo in England: in a
recent poll, fewer
than half of the Europeans questioned
thought biotechnical
research on farm an·
imals for disease resistance or increased
growth should be encouraged.
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